Get All Access for FREE

Market News & Research,
Fundamental Data,
Live Transcripts & Audio,
AlphaGraphics,

and a whole lot more…

{{::item.ticker}} • {{::item.company_name}} No Results

Get All Access for FREE

Market News & Research,
Fundamental Data,
Live Transcripts & Audio,
AlphaGraphics,

and a whole lot more…

News & Research
Portfolio
Discover
Groups
$LDL {{ '2016-07-08T16:38:35+0000' | timeago}} • Announcement

$LDL said acquisition was financed through combination of cash on hand and $85MM of borrowings from amended revolving credit facility, which was increased to $175MM. The amended facility provides additional capacity to support organic growth programs, fund capital investments and continue pursuits of attractive acquisitions.

$A {{ '2018-05-14T21:28:37+0000' | timeago}} • Infographic

$A Agilent Technologies, Inc. Earnings AlphaGraph: Q2 2018 Highlights

$A {{ '2018-01-19T17:03:14+0000' | timeago}} • Announcement

$A elected Dow Wilson, CEO of Varian Medical Systems Inc., to its BoD, effective March 20, 2018. Wilson is also a board member of AdvaMed, a U.S. trade association representing 80% of the medical technology firms in the U.S., and Varex Imaging Corp., which was created through the successful spin-off of Varian Medical.

$CBT {{ '2018-01-19T16:33:24+0000' | timeago}} • Announcement

$CBT elected Cynthia Arnold to its BoD, effective Jan. 18, 2018. She was also appointed a member of the Compensation Committee. $CBT elected Sue Rataj as Non-Executive Chair of the Board of Directors, effective March 9, 2018. $CBT said Roderick MacLeod will retire from the Board, effective at annual meeting that will be held on March 8, 2018.

$CBT {{ '2018-01-16T11:50:12+0000' | timeago}} • Announcement

$CBT's BoD declared a quarterly dividend of $0.315 per share on all outstanding shares of its common stock. The dividend is payable on March 9, 2018, to stockholders of record at the close of business on Feb. 23, 2018.

$A {{ '2018-01-09T19:50:20+0000' | timeago}} • Announcement

$A acquired Cork, Ireland-based Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell assay kits. This acquisition expands $A's cell analysis portfolio with the addition of easy-to-use assay kits that are compatible with industry standard plate-readers.  Financial terms of the deal were not disclosed.

$MEI {{ '2017-12-15T18:22:56+0000' | timeago}} • Announcement

Electronics company $MEI has declared a quarterly dividend of $0.11 per share on its common stock, representing a 22% increase versus the previous dividend. The dividend is payable on January 26, 2018, to stockholders of record on January 12, 2018.

$MEI {{ '2017-12-07T12:33:34+0000' | timeago}} • Announcement

$MEI updated its FY18 guidance to sales in the range of $880-900MM from $807-827MM, mainly due to incremental sales from acquisitions. The company, however, maintained its FY18 pre-tax income from operations in the range of $114-127MM and EPS in the range of $2.43-2.63.

$MEI {{ '2017-12-07T12:24:05+0000' | timeago}} • Announcement

Developer of custom engineered and application specific products and solutions, $MEI posted a 2.8% fall in 2Q18 profit, driven by higher expenses, lower sales volume in the Interface segment and unfavorable currency impact. Profit fell to $24.2MM or $0.64 per share from $24.9MM or $0.66 a year earlier. Revenue however, jumped 9.9% to $230.1MM.

$POWL {{ '2017-12-05T22:03:25+0000' | timeago}} • Announcement

$POWL expects to report a net loss for FY18, due in part to the need to continue managing production gaps in many of its factories and the quality of its current backlog.

$POWL {{ '2017-12-05T22:00:10+0000' | timeago}} • Announcement

$POWL's new orders placed during 4Q17 totaled $112MM compared to $111MM in 4Q16. The company's backlog as of September 30, 2017 was $250MM compared to $291MM at the end of 4Q16.

$POWL {{ '2017-12-05T21:54:53+0000' | timeago}} • Announcement

$POWL reported a net loss of $5.1MM or $0.45 per share in 4Q17 compared to a net income of $5.5MM or $0.48 per share in 4Q16. Adjusted net loss for 4Q17 was $4.8MM or $0.42 per share. Revenues were $95MM compared to $129.8MM last year.

$DCI {{ '2017-11-30T12:51:41+0000' | timeago}} • Announcement

$DCI reported a 5% YoY growth in earnings to $60.9MM, or $0.46 per share, for 1Q18. Excluding items, EPS grew 21% YoY. Sales increased 16.6% to $644.8MM, with Engine segment up 25% and Industrial up 1.8%. The company expects FY18 GAAP EPS between $1.90 and $2.04, up 6% from prior forecast. Sales to increase 10-14% vs. the prior forecast of 4-8%.

$A {{ '2017-11-21T15:04:12+0000' | timeago}} • Webcast

For FY18, $A expects pharma to moderate down slightly from a 6% growth rate delivered in FY17. Agilent expects China to maintain a high-single-digit growth rate. For Europe and the chemical and energy markets, while Agilent experienced unexpectedly strong FY17 growth, the company cautiously guided to lower growth in FY18.

$A {{ '2017-11-20T21:43:30+0000' | timeago}} • Announcement

$A expects 1Q18 revenue of $1.145-1.165Bil. First-quarter non-GAAP earnings are expected to be in the range of $0.55 to $0.57 per share. For FY18, Agilent expects revenue of $4.72-4.74Bil and non-GAAP earnings of $2.50-2.56 per share.

$A {{ '2017-11-20T21:40:09+0000' | timeago}} • Announcement

With net revenue soaring 7% to $1.19Bil in 4Q17, $A posted a 40% jump in net income of $177MM or $0.54 per diluted share.

$DCI {{ '2017-11-17T19:17:37+0000' | timeago}} • Announcement

$DCI has declared a regular cash dividend of 18.0 cents per share on its common stock. The dividend is payable on December 21, 2017, to shareholders of record on December 6, 2017.

$ESE {{ '2017-11-14T21:39:03+0000' | timeago}} • Announcement

$ESE said it expects 2H18 sales and EPS to be significantly stronger than 1H18. Meanwhile, the company expects 1Q18 GAAP EPS to be in the range of $0.28 to $0.33 per share.

$ESE {{ '2017-11-14T21:36:33+0000' | timeago}} • Announcement

In FY18, $ESE expects sales to grow approx 13% YoY, and adjusted EBITDA to increase 15-17%. The company projects FY18 GAAP EPS to be in the range of $2.30 to $2.40 per share, including the profit contributions from the recent acquisitions.

$ESE {{ '2017-11-14T21:31:47+0000' | timeago}} • Announcement

$ESE, a provider of engineered products and solutions, reported 30% jump in net sales to $207MM in 4Q17. Net income rose to $19.2MM, or $0.74 per share, compared to $16.9MM, or $0.65 per share in the year-over period. On an adjusted basis, net income rose to $0.79 per share.

$CBT {{ '2017-10-10T21:17:19+0000' | timeago}} • Announcement

$CBT has indefinitely idled three of the seven production units at its activated carbon manufacturing facility in Texas, due to reduction in demand. $CBT expects this to result in a pretax charge to earnings of approx. $9MM, of which less than $1MM is cash. Annual savings are estimated to be approx. $6MM, of which approx. $5MM is cash.

Recent Transcripts
VPG | Earnings
February 20th 2019, 3:00pm
FARO | Earnings
February 20th 2019, 1:15pm
CYBE | Earnings
February 19th 2019, 9:30pm
AXDX | Earnings
February 19th 2019, 9:30pm
AlphaGraphics you may like
Related Feed
Recent Transcripts
VPG | Earnings
February 20th 2019, 3:00pm
FARO | Earnings
February 20th 2019, 1:15pm
CYBE | Earnings
February 19th 2019, 9:30pm
AXDX | Earnings
February 19th 2019, 9:30pm
AlphaGraphics you may like